IDA MedProHealth Pharmacy

Site: Burlington - Thomas Alton Blvd

Service: Pharmacy Services

Record #: BTN5996
Last Full Update: 11 Dec 2023

Memos and Bulletins

Public Comments

Pharmacists can now treat and prescribe medications for 19 common medical ailments and renew prescriptions for most medications

Contact Information

Office Phone 905-336-0999
Fax 905-319-6151
Website www.guardian-ida-remedysrx.ca/en/ontario/burlington/medprohealth-pharmacy-7021180
Social Media Facebook Facebook

Site Information

Located In Community Burlington
Address & Map
4903 Thomas Alton Blvd, Unit 104
Burlington, ON L7M 0W8
 
View Google Map
Intersection Appleby Line and Dundas St
Physical Access Partially Accessible - wheelchair accessible door but no automatic door opener at main entrance ; Designated parking at entrance ; Dedicated accessible washroom with all features

Agency Information

Description (Agency)

A community pharmacy

Legal Status (60) Commercial
Established 2016
Funding Sale of Goods

Description and Service Details

Description (Service)

General pharmacy

Services include:

  • delivery of prescriptions for free
  • disease management and counselling
  • immunizations 

Medications Return Program:

  • safe disposal of expired or unused prescription drugs, over-the-counter medications, natural health products and medications for companion animals

MedsCheck:

  • appointments to review complex prescriptions with a pharmacist  

Sharps Collection Program:

  • safe disposal of needles, syringes, infusion sets, lancets, pen tips, pre-filled syringes, cartridges and auto-injectors 
Hours
  • Mon-Tue 9 am-8 pm
  • Wed-Fri 9 am-7 pm
  • Sat 10 am-4 pm
Areas Served Burlington
Eligibility No restrictions
Application

No application required

Languages English
Fees

Dispensing fee plus medication costs

  • prescribed medications may be covered by OHIP

Any omissions are unintentional and HIP disclaims any liability for unauthorized use or reproduction of any portion of this site. For a complete copyright and license statement please refer to our Terms of Use.